Platelet Function and Risk of Bleeding in Patients With Acute Coronary Syndrome Following Tirofiban Infusion
Aim: To assess platelet (PLT) function and bleeding risks in patients with acute coronary syndrome after tirofiban infusion.Methods: Patients diagnosed with acute coronary syndrome from May 2016 to February 2018 in the Department of Cardiac Intensive Care Unit, Zhongshan Hospital, were enrolled. The...
Main Authors: | Xiaoye Li, Shuning Zhang, Zi Wang, Qiuyi Ji, Qibing Wang, Xiaoyu Li, Qianzhou Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01158/full |
Similar Items
-
High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Taner Ulus, et al.
Published: (2017-03-01) -
Predictors and Management of Antiplatelet-Related Bleeding Complications for Acute Coronary Syndrome in Chinese Elderly Patients
by: Jindong Wan, et al.
Published: (2018-10-01) -
Effect of preoperative small dose of tirofiban on PCI treatment in patients with acute coronary syndrome
by: Li Wang, et al.
Published: (2016-06-01) -
A misleading diagnosis in acute coronary syndrome: tirofiban-induced alveolar hemorrhage
by: Bahadır Şarlı, et al.
Published: (2015-12-01) -
Evaluation of CRUSADE and ACUITY-HORIZONS Scores for Predicting Long-term Out-of-Hospital Bleeding after Percutaneous Coronary Interventions
by: Xue-Yan Zhao, et al.
Published: (2018-01-01)